Skip to content
Menu

Standard BioTools Inc. LAB

Full chart Compare
Set alert

Price alert · LAB

All alert types
0.61 USD +0.04 (+7.67%)

Regular-session close

0.62 +0.01 +1.03%

Pre-market · Nov 20, 5:04 AM ET

0.562 Day range 0.6302
0.39 52-week range 1.72
YTD
-52.05%
1 year
-52.05%

LAB revenue history

Revenue is income from the company’s ordinary business activities.

85,331,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-3185,331,000-5,677,000-6.24%
FY 20242024-12-3191,008,000-15,332,000-14.42%
FY 20232023-12-31106,340,0008,392,0008.57%
FY 20222022-12-3197,948,000-32,633,000-24.99%
FY 20212021-12-31130,581,000-7,563,000-5.47%
FY 20202020-12-31138,144,00020,901,00017.83%
FY 20192019-12-31117,243,0004,279,0003.79%
FY 20182018-12-31112,964,00011,027,00010.82%
FY 20172017-12-31101,937,000-2,509,000-2.40%
FY 20162016-12-31104,446,000-10,266,000-8.95%
FY 20152015-12-31114,712,000-1,744,000-1.50%
FY 20142014-12-31116,456,00045,273,00063.60%
FY 20132013-12-3171,183,00018,849,00036.02%
FY 20122012-12-3152,334,0009,469,00022.09%
FY 20112011-12-3142,865,0009,305,00027.73%
FY 20102010-12-3133,560,0008,148,00032.06%
FY 20092009-12-3125,412,00010,065,00065.58%
FY 20082008-12-2715,347,0008,072,000110.96%
FY 20072007-12-297,275,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-08-07T06:02:19.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.